Mol. Cells 2018; 41(12): 1000-1007
Published online December 12, 2018
https://doi.org/10.14348/molcells.2018.0438
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: ktaimin@unist.ac.kr
Mitochondria and endoplasmic reticulum (ER) are essential organelles in eukaryotic cells, which play key roles in various biological pathways. Mitochondria are responsible for ATP production, maintenance of Ca2+ homeostasis and regulation of apoptosis, while ER is involved in protein folding, lipid metabolism as well as Ca2+ homeostasis. These organelles have their own functions, but they also communicate via mitochondrial-associated ER membrane (MAM) to provide another level of regulations in energy production, lipid process, Ca2+ buffering, and apoptosis. Hence, defects in MAM alter cell survival and death. Here, we review components forming the molecular junctions of MAM and how MAM regulates cellular functions. Furthermore, we discuss the effects of impaired ER-mitochondrial communication in various neurodegenerative diseases.
Keywords ER-mitochondria tethering, mitochondrial-associated ER membrane (MAM), neurodegenerative disease
The interface between ER and mitochondria is called mitochondrial-associated ER membrane (MAM) (Fig. 1 and Table 1). Numerous studies found different molecules in MAM and have attempted to investigate biological roles of MAM, but it still is not yet fully understood. In yeast cells, a structure of protein complexes that connects ER and mitochondria called the ER-mitochondria encounter structure (ERMES), has been reported to contain Mdm12, Mdm34, Mdm10 and Mmm1 proteins (Kornmann et al., 2009). Mdm12 is a linker protein connecting ER membrane protein Mmm1 to mitochondrial outer membrane proteins, Mdm34 or Mdm10. This physical tethering establishes ERMES, which then allow efficient lipid transport by soluble lipid-carrier proteins such as CERT and OSBP (D’Angelo et al., 2008). Mutant proteins disrupting ERMES cause defects in phospholipid exchange between ER and mitochondria, resulting in impaired cellular growth or organelle recycling (Kornmann et al., 2009).
Mammalian cells have more complicated protein complexes in the ER-mitochondria interface. Proteins in MAM either play a direct role in physical connection between ER and mitochondria or modulates the tethering complexes in MAM. MFN1 and 2 (MFN1/2), a mitochondrial fusion GTPase, localized to the outer membrane of mitochondria is found in the MAM complex. MFN1/2 plays a role in mitochondrial fusion together with OPA1, another mitochondrial fusion GTPase, located on the inner membrane of mitochondria (Cipolat et al., 2004). During mitochondrial fusion process, mitochondrial MFN1/2 assembles homo- or heterodimer complexes with MFN2 presented in ER membrane (de Brito and Scorrano, 2008; Detmer and Chan, 2007). Fis1 and BAP31 interaction is also found in MAM (Iwasawa et al., 2011). Fis1 located on the mitochondrial outer membrane recruits dynamin related protein 1 (DRP1) to mitochondrial fission sites (Stojanovski et al., 2004). BAP31 is a chaperone located on the ER membrane, which regulates degradation of misfolded protein and apoptotic pathway (Nguyen et al., 2000; Wakana et al., 2008). When Fis1 binds to BAP31 in MAM, apoptotic signals is conveyed to ER, initiating apoptotic pathway (Iwasawa et al., 2011). Another interaction at the interface of ER and mitochondria occurs between PTPIP51 and VAPB (De Vos et al., 2012). While PTPIP51 is a mitochondrial outer membrane protein that modulates cellular development and tumorigenesis (Yu et al., 2008); VAPB is an ER membrane protein involved in vesicle trafficking and unfolded protein response (Kanekura et al., 2006; Nishimura et al., 2004). However, VABP and PTPIP51 complex in MAM acts on different pathways such as Ca2+ regulation and autophagy (De Vos et al., 2012; Gomez-Suaga et al., 2017). PTPIP51 also connects to other mitochondrial proteins, ORP5 and ORP8 found in MAM. It is reported that mutations in the
Several proteins are reported to mediate ER-mitochondria communications by interacting with the ER-mitochondria tethering protein complexes. Phosphofurin acidic cluster sorting 2 protein (PACS-2) is a multifunctional cytoplasmic protein, which controls ER quality and induces apoptosis (Myhill et al., 2008; Simmen et al., 2005). Whether PACS-2 directly attaches to MAM is not clear, however, depletion of PACS-2 causes reduction of ER-mitochondria contact and generation of mitochondrial fragmentation (Simmen et al., 2005), suggesting that PACS-2 modulates ER-mitochondria contacts. Sigma non-opioid intracellular receptor 1 (SigR1) and Tespa1 associate with the IP3R-Grp75-VDAC-MCU calcium axis in MAM. Overexpression of SigR1 increases Ca2+ flux from the ER by interacting with Ankyrin and ER chaperone protein, BiP (Su et al., 2016; Wu and Bowen, 2008). Tespa1 binds to both IP3R and Grp75, and Tespa1 knockdown decreases the levels of mitochondrial and cytoplasmic Ca2+ (Matsuzaki et al., 2013), however its mechanism is not known. FUN14 domain containing 1 (FUNDC1) is another protein that modulates MAM dynamics. FUNDC1 interacts with Calnexin, a ER chaperone protein, and this binding competes with FUNDC1’s binding to Drp1 during early hypoxia. In later hypoxia condition FUNDC1 dissociates from Calnexin and instead interacts with Drp1, which then induces mitochondrial fission and mitophagy (Wu et al., 2016). Presenilin (PS) is a multifunctional protein involved in amyloid beta (Aβ) production pathway, and it is known that PS mutants cause familial Alzheimer’s disease (AD) (De Strooper, 2007). Interestingly, PS affects Ca2+ dynamics in MAM by interacting with MFN2. Thus, mutations in the
Physical interactions linking ER and mitochondria play roles not only in Ca2+ homeostasis and apoptosis, but in lipid transferring between the two organelles. Lipid synthesis is performed mostly in the ER but still requires cooperation of enzymes on the mitochondrial membrane, because ER and mitochondria have distinct lipid processing enzymes. For example, newly synthesized phosphatidylserine (PS) in ER is transferred to the mitochondrial inner membrane, where it converts to phosphatidylethanolamine (PE) by PS decarboxylase (PSD). PE then transports back to the ER membrane through MAM contact (Vance, 2014). While various studies have discovered molecules involved in the MAM structure and functions, a comprehensive understanding of the complex MAM system is still lacking.
ER is the major site of Ca2+ storage within a cell, and IP3R on ER is highly accumulated in MAM (Marchi and Pinton, 2014; Patergnani et al., 2011). Numerous forms of interactions between Ca2+ channels and regulators are found in MAM, which regulate Ca2+-dependent cellular functions as well as maintain Ca2+ homeostasis. Furthermore, elevated Ca2+ level in MAM activates Ca2+ influx to mitochondria through the IP3R-Grp75-VDAC-MCU complex. When the linker protein Grp75 is reduced, mitochondrial Ca2+ level is decreased, suggesting that Grp75 connects ER and mitochondria indirectly by interacting with both IP3R and VDAC. The resulting apposition of ER and mitochondria facilitates Ca2+ transfer from ER to mitochondria. Indeed, Grp75 knockdown prevents cell death due to excess Ca2+ in mitochondria (Honrath et al., 2017).
Proteins associated with the IP3R-Grp75-VDAC-MCU complex can modulate Ca2+ transfer between ER and mitochondria. SigR1 interacts with BiP in normal condition. However, when ER is under stress or when ER Ca2+ is depleted, SigR1 switches its interacting partner from BiP to IP3R. This process protects IP3R from degradation, resulting in restoration of Ca2+ transfer from the ER to mitochondria (Hayashi and Su, 2007). Tespa-1 binds to both Grp75 and IP3R in T-cells. Knockout of Tespa-1 impairs Ca2+ flux to both cytosol and mitochondria, which causes decreased Ca2+ signaling and ERK activation (Liang et al., 2017; Matsuzaki et al., 2012), suggesting that the Tespa-1-Grp75-IP3R complex regulates Ca2+ efflux from ER to cytosol or mitochondria. Other physical tethering complexes in MAM that facilitate efficient Ca2+ transfer between ER and mitochondria are the VAPB-PTPIP51 complex and the MFN complex. For example, genetic modification of the
Since energy production and cell death can be triggered by different levels of Ca2+, MAM plays a key role in delicate refinement of Ca2+ level in mitochondria. Upregulation of mitochondrial Ca2+ in physiological condition activates mitochondrial enzymes, which facilitates TCA cycle and oxidative phosphorylation. Activities of α-ketoglutarate dehydrogenase, isocitrate dehydrogenase and pyruvate dehydrogenase are Ca2+- dependent enzymes (McCormack and Denton, 1993). ATP synthase is also Ca2+-dependent enzyme (Das and Harris, 1990). Thus, increased Ca2+ level in mitochondria enhances electron activity, resulting in elevated generation of ATP (Hansford and Zorov, 1998). In contrast, prolonged or excessive mitochondrial Ca2+ level activates apoptotic pathway. Increased Ca2+ flux from ER to mitochondria initiates oligomerization of Bcl-2-associated X protein (BAX), which translocates to mitochondrial membrane and increases permeability of mitochondrial membrane (Rostovtseva et al., 2005). Furthermore, mitochondrial permeability transition pore (PTP) is induced by high level of Ca2+ (Haworth and Hunter, 1979). PTP also increases mitochondrial membrane permeability, leading to apoptosis by releasing cytochrome c, apoptosis-inducing factor (AIF), and Smac/DIABLO (Petronilli et al., 2001). Cytochrome c and AIF initiates apoptosis through caspase cascade pathway, but Smac/DIABLO triggers cell death independently from the caspase cascade (Kroemer et al., 2007). Furthermore, MAM proteins such as PACS-2, Bid, Fis1, and Bap31 are involved in apoptosis. PACS-2 initiates apoptosis by recruiting Bid into mitochondrial membrane upon activation of cell death signals. To activate Bid, Fis1 cleaves Bap31 into p20Bap31, proapoptotic molecule, followed by p20Bap31 converting procaspase-8 to caspase-8 (Iwasawa et al., 2011). Caspase-8 then activates Bid, allowing releasing cytochrome c from mitochondria, which then forms apoptosome with caspase-3, 7 and 9 (Simmen et al., 2005).
Impaired ER-mitochondrial communications may lead to metabolic diseases, cancers, and neurodegenerative diseases. Numerous studies have observed structural or functional changes in MAM in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS). AD is a neurodegenerative disease characterized by progressive loss of cognitive functions. AD patient brains contain accumulation of amyloid plaque composed of primarily of Aβ and neurofibrillary tangles containing mostly hyperphosphorylated Tau. PS is a subunit protein of γ-secretase, involved in the processing of amyloid precursor protein (APP). Several mutations in
PD is a neurodegenerative disease that causes tremor and a progressive loss of movement, which are associated with degeneration of dopaminergic neurons in substantia nigra in the brain. Dopaminergic neurons in PD contain Lewy bodies, composed of mostly aggregation of α-synuclein (α-syn) (Maries et al., 2003). The α-syn protein is also enriched in MAM (Guardia-Laguarta et al., 2014). Mutations are found in the α
ALS is a neurodegenerative disease caused by loss of motor neurons, resulting in gradual deterioration of muscles. Although SOD1 and other candidate genes are reported to associate with familial ALS, the exact cause of ALS is still not clear. However, a mutation in
In this review, we discuss the molecular compositions and functions of ER-mitochondria interface. It is now clear that various molecules in the ER-mitochondria tethering complex are important for Ca2+ or lipid homeostasis, and for cell survival and apoptotic regulation. Moreover, several proteins disrupting MAM structure or functions have been identified in neurodegenerative diseases such as AD, PD, and ALS. While numerous molecules have been found in MAM, new molecules that affect MAM are still being identified. This implies that new MAM functions are waiting to be discovered in different cellular environments, cell types, and disease conditions. Furthermore, the underlying mechanism of how MAM is associated with neurological disorders is not fully understood. Thus, future studies will require considerable efforts to precisely delineate the structure and function of MAM. A better understanding of MAM may contribute to new strategies to treat and prevent neurodegenerative diseases in the future.
List of protein components involved in MAM
Species | Protein components | Biological roles | Possible related diseases | Reference |
---|---|---|---|---|
Yeast | Mmm1-Mdm12-Mdm34-Mdm10 | Efficient phospholipid exchange | Kornmann et al., 2009 | |
Mammalian | IP3R-Grp75-VDAC1 | Ca2+ regulation | PD | Szabadkai et al., 2006; Davison et al., 2009 |
BAP31-Fis1 | Initiation of apoptosis | Iwasawa et al., 2011 | ||
VAPB-PTPIP51 | Ca2+ regulation and autophagy | ALS | De Vos et al., 2012; Gomez-Suaga et al., 2017; Nishimura et al., 2004; De Vos et al., 2012 | |
ORP5/8-PTPIP51 | Lipid transfer | Galmes et al., 2016 | ||
MFN2-MFN1/2 | Physical tethering | PD | de Brito and Scorrano, 2008; McLelland et al., 2018 | |
PACS-2 | Regulation of apoptosis | AD | Simmen et al., 2005; Hedskog et al., 2013 | |
SigR1 | Ca2+ regulation by interacting with Ankyrin and BiP | AD, ALS | Su et al., 2016; Wu and Bowen, 2008; Hedskog et al., 2013; Al-Saif et al., 2011; Bernard-Marissal et al., 2015 | |
Tespa1 | Ca2+ regulation by interacting with IP3R and Grp75 | Matsuzaki et al., 2013 | ||
FUNDC1 | Regulation of mitochondrial fission and mitophagy in hypoxia condition | Wu et al., 2016 | ||
PS | Ca2+ regulation by interacting with MFN2 | AD | Filadi et al., 2016; Zampese et al., 2011; Area-Gomez et al., 2012; Cheung et al., 2008 |
Mol. Cells 2018; 41(12): 1000-1007
Published online December 31, 2018 https://doi.org/10.14348/molcells.2018.0438
Copyright © The Korean Society for Molecular and Cellular Biology.
Soyeon Lee1,2, and Kyung-Tai Min1,2,*
1Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea, 2National Creative Research Initiative Center for Proteostasis, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea
Correspondence to:*Correspondence: ktaimin@unist.ac.kr
Mitochondria and endoplasmic reticulum (ER) are essential organelles in eukaryotic cells, which play key roles in various biological pathways. Mitochondria are responsible for ATP production, maintenance of Ca2+ homeostasis and regulation of apoptosis, while ER is involved in protein folding, lipid metabolism as well as Ca2+ homeostasis. These organelles have their own functions, but they also communicate via mitochondrial-associated ER membrane (MAM) to provide another level of regulations in energy production, lipid process, Ca2+ buffering, and apoptosis. Hence, defects in MAM alter cell survival and death. Here, we review components forming the molecular junctions of MAM and how MAM regulates cellular functions. Furthermore, we discuss the effects of impaired ER-mitochondrial communication in various neurodegenerative diseases.
Keywords: ER-mitochondria tethering, mitochondrial-associated ER membrane (MAM), neurodegenerative disease
The interface between ER and mitochondria is called mitochondrial-associated ER membrane (MAM) (Fig. 1 and Table 1). Numerous studies found different molecules in MAM and have attempted to investigate biological roles of MAM, but it still is not yet fully understood. In yeast cells, a structure of protein complexes that connects ER and mitochondria called the ER-mitochondria encounter structure (ERMES), has been reported to contain Mdm12, Mdm34, Mdm10 and Mmm1 proteins (Kornmann et al., 2009). Mdm12 is a linker protein connecting ER membrane protein Mmm1 to mitochondrial outer membrane proteins, Mdm34 or Mdm10. This physical tethering establishes ERMES, which then allow efficient lipid transport by soluble lipid-carrier proteins such as CERT and OSBP (D’Angelo et al., 2008). Mutant proteins disrupting ERMES cause defects in phospholipid exchange between ER and mitochondria, resulting in impaired cellular growth or organelle recycling (Kornmann et al., 2009).
Mammalian cells have more complicated protein complexes in the ER-mitochondria interface. Proteins in MAM either play a direct role in physical connection between ER and mitochondria or modulates the tethering complexes in MAM. MFN1 and 2 (MFN1/2), a mitochondrial fusion GTPase, localized to the outer membrane of mitochondria is found in the MAM complex. MFN1/2 plays a role in mitochondrial fusion together with OPA1, another mitochondrial fusion GTPase, located on the inner membrane of mitochondria (Cipolat et al., 2004). During mitochondrial fusion process, mitochondrial MFN1/2 assembles homo- or heterodimer complexes with MFN2 presented in ER membrane (de Brito and Scorrano, 2008; Detmer and Chan, 2007). Fis1 and BAP31 interaction is also found in MAM (Iwasawa et al., 2011). Fis1 located on the mitochondrial outer membrane recruits dynamin related protein 1 (DRP1) to mitochondrial fission sites (Stojanovski et al., 2004). BAP31 is a chaperone located on the ER membrane, which regulates degradation of misfolded protein and apoptotic pathway (Nguyen et al., 2000; Wakana et al., 2008). When Fis1 binds to BAP31 in MAM, apoptotic signals is conveyed to ER, initiating apoptotic pathway (Iwasawa et al., 2011). Another interaction at the interface of ER and mitochondria occurs between PTPIP51 and VAPB (De Vos et al., 2012). While PTPIP51 is a mitochondrial outer membrane protein that modulates cellular development and tumorigenesis (Yu et al., 2008); VAPB is an ER membrane protein involved in vesicle trafficking and unfolded protein response (Kanekura et al., 2006; Nishimura et al., 2004). However, VABP and PTPIP51 complex in MAM acts on different pathways such as Ca2+ regulation and autophagy (De Vos et al., 2012; Gomez-Suaga et al., 2017). PTPIP51 also connects to other mitochondrial proteins, ORP5 and ORP8 found in MAM. It is reported that mutations in the
Several proteins are reported to mediate ER-mitochondria communications by interacting with the ER-mitochondria tethering protein complexes. Phosphofurin acidic cluster sorting 2 protein (PACS-2) is a multifunctional cytoplasmic protein, which controls ER quality and induces apoptosis (Myhill et al., 2008; Simmen et al., 2005). Whether PACS-2 directly attaches to MAM is not clear, however, depletion of PACS-2 causes reduction of ER-mitochondria contact and generation of mitochondrial fragmentation (Simmen et al., 2005), suggesting that PACS-2 modulates ER-mitochondria contacts. Sigma non-opioid intracellular receptor 1 (SigR1) and Tespa1 associate with the IP3R-Grp75-VDAC-MCU calcium axis in MAM. Overexpression of SigR1 increases Ca2+ flux from the ER by interacting with Ankyrin and ER chaperone protein, BiP (Su et al., 2016; Wu and Bowen, 2008). Tespa1 binds to both IP3R and Grp75, and Tespa1 knockdown decreases the levels of mitochondrial and cytoplasmic Ca2+ (Matsuzaki et al., 2013), however its mechanism is not known. FUN14 domain containing 1 (FUNDC1) is another protein that modulates MAM dynamics. FUNDC1 interacts with Calnexin, a ER chaperone protein, and this binding competes with FUNDC1’s binding to Drp1 during early hypoxia. In later hypoxia condition FUNDC1 dissociates from Calnexin and instead interacts with Drp1, which then induces mitochondrial fission and mitophagy (Wu et al., 2016). Presenilin (PS) is a multifunctional protein involved in amyloid beta (Aβ) production pathway, and it is known that PS mutants cause familial Alzheimer’s disease (AD) (De Strooper, 2007). Interestingly, PS affects Ca2+ dynamics in MAM by interacting with MFN2. Thus, mutations in the
Physical interactions linking ER and mitochondria play roles not only in Ca2+ homeostasis and apoptosis, but in lipid transferring between the two organelles. Lipid synthesis is performed mostly in the ER but still requires cooperation of enzymes on the mitochondrial membrane, because ER and mitochondria have distinct lipid processing enzymes. For example, newly synthesized phosphatidylserine (PS) in ER is transferred to the mitochondrial inner membrane, where it converts to phosphatidylethanolamine (PE) by PS decarboxylase (PSD). PE then transports back to the ER membrane through MAM contact (Vance, 2014). While various studies have discovered molecules involved in the MAM structure and functions, a comprehensive understanding of the complex MAM system is still lacking.
ER is the major site of Ca2+ storage within a cell, and IP3R on ER is highly accumulated in MAM (Marchi and Pinton, 2014; Patergnani et al., 2011). Numerous forms of interactions between Ca2+ channels and regulators are found in MAM, which regulate Ca2+-dependent cellular functions as well as maintain Ca2+ homeostasis. Furthermore, elevated Ca2+ level in MAM activates Ca2+ influx to mitochondria through the IP3R-Grp75-VDAC-MCU complex. When the linker protein Grp75 is reduced, mitochondrial Ca2+ level is decreased, suggesting that Grp75 connects ER and mitochondria indirectly by interacting with both IP3R and VDAC. The resulting apposition of ER and mitochondria facilitates Ca2+ transfer from ER to mitochondria. Indeed, Grp75 knockdown prevents cell death due to excess Ca2+ in mitochondria (Honrath et al., 2017).
Proteins associated with the IP3R-Grp75-VDAC-MCU complex can modulate Ca2+ transfer between ER and mitochondria. SigR1 interacts with BiP in normal condition. However, when ER is under stress or when ER Ca2+ is depleted, SigR1 switches its interacting partner from BiP to IP3R. This process protects IP3R from degradation, resulting in restoration of Ca2+ transfer from the ER to mitochondria (Hayashi and Su, 2007). Tespa-1 binds to both Grp75 and IP3R in T-cells. Knockout of Tespa-1 impairs Ca2+ flux to both cytosol and mitochondria, which causes decreased Ca2+ signaling and ERK activation (Liang et al., 2017; Matsuzaki et al., 2012), suggesting that the Tespa-1-Grp75-IP3R complex regulates Ca2+ efflux from ER to cytosol or mitochondria. Other physical tethering complexes in MAM that facilitate efficient Ca2+ transfer between ER and mitochondria are the VAPB-PTPIP51 complex and the MFN complex. For example, genetic modification of the
Since energy production and cell death can be triggered by different levels of Ca2+, MAM plays a key role in delicate refinement of Ca2+ level in mitochondria. Upregulation of mitochondrial Ca2+ in physiological condition activates mitochondrial enzymes, which facilitates TCA cycle and oxidative phosphorylation. Activities of α-ketoglutarate dehydrogenase, isocitrate dehydrogenase and pyruvate dehydrogenase are Ca2+- dependent enzymes (McCormack and Denton, 1993). ATP synthase is also Ca2+-dependent enzyme (Das and Harris, 1990). Thus, increased Ca2+ level in mitochondria enhances electron activity, resulting in elevated generation of ATP (Hansford and Zorov, 1998). In contrast, prolonged or excessive mitochondrial Ca2+ level activates apoptotic pathway. Increased Ca2+ flux from ER to mitochondria initiates oligomerization of Bcl-2-associated X protein (BAX), which translocates to mitochondrial membrane and increases permeability of mitochondrial membrane (Rostovtseva et al., 2005). Furthermore, mitochondrial permeability transition pore (PTP) is induced by high level of Ca2+ (Haworth and Hunter, 1979). PTP also increases mitochondrial membrane permeability, leading to apoptosis by releasing cytochrome c, apoptosis-inducing factor (AIF), and Smac/DIABLO (Petronilli et al., 2001). Cytochrome c and AIF initiates apoptosis through caspase cascade pathway, but Smac/DIABLO triggers cell death independently from the caspase cascade (Kroemer et al., 2007). Furthermore, MAM proteins such as PACS-2, Bid, Fis1, and Bap31 are involved in apoptosis. PACS-2 initiates apoptosis by recruiting Bid into mitochondrial membrane upon activation of cell death signals. To activate Bid, Fis1 cleaves Bap31 into p20Bap31, proapoptotic molecule, followed by p20Bap31 converting procaspase-8 to caspase-8 (Iwasawa et al., 2011). Caspase-8 then activates Bid, allowing releasing cytochrome c from mitochondria, which then forms apoptosome with caspase-3, 7 and 9 (Simmen et al., 2005).
Impaired ER-mitochondrial communications may lead to metabolic diseases, cancers, and neurodegenerative diseases. Numerous studies have observed structural or functional changes in MAM in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS). AD is a neurodegenerative disease characterized by progressive loss of cognitive functions. AD patient brains contain accumulation of amyloid plaque composed of primarily of Aβ and neurofibrillary tangles containing mostly hyperphosphorylated Tau. PS is a subunit protein of γ-secretase, involved in the processing of amyloid precursor protein (APP). Several mutations in
PD is a neurodegenerative disease that causes tremor and a progressive loss of movement, which are associated with degeneration of dopaminergic neurons in substantia nigra in the brain. Dopaminergic neurons in PD contain Lewy bodies, composed of mostly aggregation of α-synuclein (α-syn) (Maries et al., 2003). The α-syn protein is also enriched in MAM (Guardia-Laguarta et al., 2014). Mutations are found in the α
ALS is a neurodegenerative disease caused by loss of motor neurons, resulting in gradual deterioration of muscles. Although SOD1 and other candidate genes are reported to associate with familial ALS, the exact cause of ALS is still not clear. However, a mutation in
In this review, we discuss the molecular compositions and functions of ER-mitochondria interface. It is now clear that various molecules in the ER-mitochondria tethering complex are important for Ca2+ or lipid homeostasis, and for cell survival and apoptotic regulation. Moreover, several proteins disrupting MAM structure or functions have been identified in neurodegenerative diseases such as AD, PD, and ALS. While numerous molecules have been found in MAM, new molecules that affect MAM are still being identified. This implies that new MAM functions are waiting to be discovered in different cellular environments, cell types, and disease conditions. Furthermore, the underlying mechanism of how MAM is associated with neurological disorders is not fully understood. Thus, future studies will require considerable efforts to precisely delineate the structure and function of MAM. A better understanding of MAM may contribute to new strategies to treat and prevent neurodegenerative diseases in the future.
. List of protein components involved in MAM.
Species | Protein components | Biological roles | Possible related diseases | Reference |
---|---|---|---|---|
Yeast | Mmm1-Mdm12-Mdm34-Mdm10 | Efficient phospholipid exchange | Kornmann et al., 2009 | |
Mammalian | IP3R-Grp75-VDAC1 | Ca2+ regulation | PD | Szabadkai et al., 2006; Davison et al., 2009 |
BAP31-Fis1 | Initiation of apoptosis | Iwasawa et al., 2011 | ||
VAPB-PTPIP51 | Ca2+ regulation and autophagy | ALS | De Vos et al., 2012; Gomez-Suaga et al., 2017; Nishimura et al., 2004; De Vos et al., 2012 | |
ORP5/8-PTPIP51 | Lipid transfer | Galmes et al., 2016 | ||
MFN2-MFN1/2 | Physical tethering | PD | de Brito and Scorrano, 2008; McLelland et al., 2018 | |
PACS-2 | Regulation of apoptosis | AD | Simmen et al., 2005; Hedskog et al., 2013 | |
SigR1 | Ca2+ regulation by interacting with Ankyrin and BiP | AD, ALS | Su et al., 2016; Wu and Bowen, 2008; Hedskog et al., 2013; Al-Saif et al., 2011; Bernard-Marissal et al., 2015 | |
Tespa1 | Ca2+ regulation by interacting with IP3R and Grp75 | Matsuzaki et al., 2013 | ||
FUNDC1 | Regulation of mitochondrial fission and mitophagy in hypoxia condition | Wu et al., 2016 | ||
PS | Ca2+ regulation by interacting with MFN2 | AD | Filadi et al., 2016; Zampese et al., 2011; Area-Gomez et al., 2012; Cheung et al., 2008 |
Sangwoo Ham, Hyojung Kim, Seojin Hwang, Hyunook Kang, Seung Pil Yun, Sangjune Kim, Donghoon Kim, Hyun Sook Kwon, Yun-Song Lee, MyoungLae Cho, Heung-Mook Shin, Heejung Choi, Ka Young Chung, Han Seok Ko, Gum Hwa Lee, and Yunjong Lee
Mol. Cells 2019; 42(6): 480-494 https://doi.org/10.14348/molcells.2019.0091